Intensified antineoplastic effect by combining an HDAC-inhibitor, an mTOR-inhibitor and low dosed interferon alpha in prostate cancer cells

A significant proportion of men diagnosed with prostate cancer (PCa) eventually develop metastatic disease, which progresses to castration resistance, despite initial response to androgen deprivation. As anticancer therapy has become increasingly effective, acquired drug resistance has emerged, limi...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsaur, Igor, Hudak, Lukasz, Makarević, Jasmina, Juengel, Eva, Mani, Jens, Borgmann, Hendrik, Gust, Kilian M, Schilling, David, Bartsch, Georg, Nelson, Karen, Haferkamp, Axel, Blaheta, Roman A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd 2015
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4549030/
https://www.ncbi.nlm.nih.gov/pubmed/25808196
http://dx.doi.org/10.1111/jcmm.12583

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4549030/
https://www.ncbi.nlm.nih.gov/pubmed/25808196
http://dx.doi.org/10.1111/jcmm.12583

Ejemplares similares